Hope for metastatic prostate cancer patients: Targeted alpha therapy shows impressive results

Nearly three years of research have brought about remarkable results for the majority of 80 patients subjected to targeted alpha therapy of metastatic prostate cancer. The first assessments describes a full response in two patients in critical clinical condition with extensive metastases.